Risk perception in drug therapy
Erratum
An update and appraisal of the cilomilast Phase III clinical development programme for chronic obstructive pulmonary disease
Effects of rac-albuterol on arterial blood gases in patients with stable hypercapnic chronic obstructive pulmonary disease
Facial thermography is a sensitive tool to determine antihistaminic activity : comparison of levocetirizine and fexofenadine
Development of a dosage strategy in patients receiving enoxaparin by continuous intravenous infusion using modelling and simulation
The effect of CYP2J2, CYP3A4, CYP3A5 and the MDR1 C3435T polymorphisms and gender on the urinary excretion of the metabolites of the H1-receptor antihistamine ebastine : a pilot study
Poor correlation between 6β-hydroxycortisol : cortisol molar ratios and midazolam clearance as measure of hepatic CYP3A activity
Major determinant factors of the extent of interaction between grapefruit juice and calcium channel antagonists
Effect of widely used combinations of antiretroviral therapy on liver CYP3A4 activity in HIV-infected patients
Multiple doses of the antimuscarinic agent solifenacin do not affect the pharmacodynamics or pharmacokinetics of warfarin or the steady-state pharmacokinetics of digoxin in healthy subjects
General practitioners' ranking of evidence-based prescribing quality indicators : a comparative study with a prescription database
Using a capture–recapture method to assess the frequency of adverse drug reactions in a French university hospital
Patients' knowledge of adverse reactions to current medications
Induction of P-glycoprotein in lymphocytes by carbamazepine and rifampicin : the role of nuclear hormone response elements
Selectivity of NSAIDs for COX-2 and cardiovascular outcome
A case of acute lead poisoning in a 2-year-old child
Spontaneous retroperitoneal haematoma associated with clopidogrel therapy mimicking acute appendicitis
The effect of the CYP2C19*2 heterozygote genotype on the pharmacokinetics of nelfinavir
Pharmacogenomics, Methods and Protocols
The Adrenergic Receptor in the 21st Century